Line 82: |
Line 82: |
| !width="150"|'''Article''' | | !width="150"|'''Article''' |
| |- | | |- |
− | |<big>'''What is type I hypersensitivity also known as?''' | + | |<big>'''What types of immunoglobulin are produced in type II hypersensitivity reactions?''' |
| ||<font color="white"> <big> | | ||<font color="white"> <big> |
− | *'''''Anaphylactic-mediated''''' | + | *'''''IgG''''' |
− | *'''''IgE-mediated''''' | + | *'''''IgM''''' |
| + | ||[[Type II Hypersensitivity - WikiBlood#Introduction|<span title="Answer article">Link to Answer Article</span>]] |
| + | |- |
| + | |<big>'''What is the main mechanism of type II hypersensitivity reactions?''' |
| + | ||<font color="white"> <big> |
| + | *'''''Neutralisation blockage of receptors''''' |
| + | ||[[Type II Hypersensitivity - WikiBlood#Mechanism|<span title="Answer article">Link to Answer Article</span>]] |
| + | |- |
| + | |<big>'''Which immunological processes does the type II reaction use to destroy target cells? Give examples for each process?''' |
| + | ||<font color="white"> <big> |
| + | *'''''Antibody dependent cell cytotoxicity (ADCC)''''' |
| + | **'''''Pemphigus vulgaris''''' |
| + | **'''''Bullous pemphigoid''''' |
| + | *'''''Complement mediated lysis''''' |
| + | **'''''Immune mediated haemolytic anaemia''''' |
| + | **'''''Blood transfusion reaction''''' |
| + | **'''''Haemolytic disease of new born''''' |
| + | **'''''Feline infectious anaemia''''' |
| + | *'''''Phagocytosis''''' |
| ||[[Type II Hypersensitivity - WikiBlood#Introduction|<span title="Answer article">Link to Answer Article</span>]] | | ||[[Type II Hypersensitivity - WikiBlood#Introduction|<span title="Answer article">Link to Answer Article</span>]] |
| |} | | |} |
| <br> | | <br> |
| <br> | | <br> |
| + | |
| ==<font color="purple">Type III Hypersensitivity</font>== | | ==<font color="purple">Type III Hypersensitivity</font>== |
| {| border="3" cellpadding="8" | | {| border="3" cellpadding="8" |